Holen Sie sich die Stockscreener-App
8.65
16.22%
-1.675
Vorhandelsmarkt:
8.65
Schlusskurs vom Vortag:
$10.32
Offen:
$10.32
24-Stunden-Volumen:
115.27K
Relative Volume:
8.06
Marktkapitalisierung:
$10.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.80M
KGV:
-7.2689
EPS:
-1.19
Netto-Cashflow:
$-25.19M
1W Leistung:
+23.57%
1M Leistung:
-4.21%
6M Leistung:
-9.90%
1J Leistung:
-33.45%
1-Tages-Spanne:
$8.045
$10.63
1-Wochen-Bereich:
$6.325
$10.99
52-Wochen-Spanne:
$5.00
$17.40
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Firmenname
Sensei Biotherapeutics Inc
Sektor
Branche
Telefon
(240) 243-8000
Adresse
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Vergleichen Sie SNSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
8.65 | 13.01M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.54 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
419.56 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
690.32 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
304.30 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2021-07-01 | Herabstufung | Berenberg | Buy → Hold |
| 2021-06-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Eingeleitet | Berenberg | Buy |
| 2021-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-01 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Sensei Biotherapeutics Inc Aktie (SNSE) Neueste Nachrichten
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Sensei's Cancer Drug Breakthrough: New Data Shows Effectiveness Where Other Treatments Failed - Stock Titan
Sensei Biotherapeutics Inc. Company Revenue and Profit Trends: A Deep DiveFree Stock Market Insider Analysis - metal.it
What institutions are buying Sensei Biotherapeutics Inc. stock nowFree Stock Market Watch With Alerts - Newser
How Sensei Biotherapeutics Inc. stock performs during market volatilityAI-Based Reversal Point Prediction Signal - Newser
Chart based analysis of Sensei Biotherapeutics Inc. trendsFree High Accuracy Alerts for ROI Traders - Newser
Smart tools for monitoring Sensei Biotherapeutics Inc.’s price actionControlled Entry Strategy With Safety Analytics - Newser
How high can Sensei Biotherapeutics Inc. stock goAI Driven Swing Trade Forecasting Insight - Newser
Using RSI to spot recovery in Sensei Biotherapeutics Inc.Risk-Managed Swing Setup and Signal Analysis - Newser
Ranking Sensei Biotherapeutics Inc. among high performing stocks via toolsMulti-Year Signal Summary and Entry Timing - Newser
Short interest data insights for Sensei Biotherapeutics Inc.Daily Trade Monitor with Pattern Alerts - Newser
How to manage a losing position in Sensei Biotherapeutics Inc.Chart Based Entry Tool for ROI Traders - Newser
What is Sensei Biotherapeutics Inc. company’s growth strategyCapitalize on high-yield stocks early - Jammu Links News
Is Sensei Biotherapeutics Inc. a growth stock or a value stockUnlock powerful market trend analysis - Jammu Links News
Is Sensei Biotherapeutics Inc. a good long term investmentCapitalize on market momentum for profits - Jammu Links News
Using data tools to time your Sensei Biotherapeutics Inc. exitFree Low Capital High Return Stock Plans - newser.com
Should I hold or sell Sensei Biotherapeutics Inc. stock in 2025Capitalize on emerging industry trends - Jammu Links News
How does Sensei Biotherapeutics Inc. generate profit in a changing economyTremendous financial leverage - Jammu Links News
How volatile is Sensei Biotherapeutics Inc. stock compared to the marketMaximize gains with professional stock picks - Jammu Links News
Published on: 2025-08-03 05:27:43 - Jammu Links News
Why Sensei Biotherapeutics Inc. stock attracts strong analyst attentionWeekly Outlook for Short Term Investors - Newser
Sensei Biotherapeutics Inc. stock momentum explainedSafe and Scalable Return Strategy Blueprint - Newser
Sensei Biotherapeutics Inc.’s volatility index tracking explainedDaily Swing Candidate Analysis with Chart Patterns - Newser
Institutional Tools Highlight Unusual Flow in Sensei Biotherapeutics Inc.AI Powered High Return Stock Calls Dominate Watchlists - metal.it
When is Sensei Biotherapeutics Inc. stock expected to show significant growthRetirement Planning Watchlist For Fast Growth - Jammu Links News
Is Sensei Biotherapeutics Inc. stock overhyped or has real potentialStrategy Chart for Real-Time Trade Flow - Newser
Sensei Biotherapeutics shares rise 8.07% intraday after announcing clinical data presentation at ESMO Congress 2025. - AInvest
Is it the right time to buy Sensei Biotherapeutics Inc. stockDaily Trading Guidance With Proven Results - jammulinksnews.com
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug At the European Society for Medical Oncology Congress 2025 - MarketScreener
Sensei Biotherapeutics to Present Clinical Data from the - GlobeNewswire
Sensei Biotherapeutics to present cancer therapy data at ESMO 2025 By Investing.com - Investing.com India
Sensei Biotherapeutics to present cancer therapy data at ESMO 2025 - Investing.com
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 - GuruFocus
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025 - The Manila Times
Breakthrough Cancer Drug Trial Results: Sensei's PD-1 Combo Therapy Shows Promise for Advanced Tumors - Stock Titan
What MACD signals say about Sensei Biotherapeutics Inc.Smart Risk Entry Zone Technical Analysis - Newser
Sensei Biotherapeutics Inc. Reversal Rally May Surprise BearsProven Entry Plan With Low Risk Shared - metal.it
Is Sensei Biotherapeutics Inc. Stock a Good Fit for Conservative InvestorsChart-Based Trade Entries Gain Analyst Support - beatles.ru
What makes Sensei Biotherapeutics Inc. stock price move sharplyDaily Trading Strategy To Watch Now - jammulinksnews.com
What is the risk reward ratio of investing in Sensei Biotherapeutics Inc. stockRapid growth trajectories - jammulinksnews.com
Applying Wyckoff theory to Sensei Biotherapeutics Inc. stockRSI and MACD Signal Summary with Trends - Newser
Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):